Chronic Myeloid Leukemia: Update 2014.
Posted on 2014-08-28Guest Editors: Michele Baccarani and Fabrizio Pane
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014010
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014037
Review ArticlesImatinib in Chronic Myeloid Leukemia: an Overview
![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014007
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014009
TYROSINE KINASE INHIBITORS AND INTERFERON![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014006
SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014003
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014005
TYROSINE KINASE INHIBITORS AND PREGNANCY![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti | DOI: 10.4084/mjhid.2014.028
e2014028
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)